Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases

S Kakavandi, I Zare, M VaezJalali, M Dadashi… - Cell Communication and …, 2023 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is caused by a new member of the
Coronaviridae family known as severe acute respiratory syndrome coronavirus 2 (SARS …

In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives

MS Sohail, SF Ahmed, AA Quadeer… - Advanced drug delivery …, 2021 - Elsevier
Growing evidence suggests that T cells may play a critical role in combating severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Hence, COVID-19 vaccines that can …

Whole‐transcriptome RNA sequencing reveals significant differentially expressed mRNAs, miRNAs, and lncRNAs and related regulating biological pathways in the …

C Li, J Chen, S Lv, J Li, L Li, X Hu - Mediators of inflammation, 2021 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) was initially identified in
China and currently worldwide dispersed, resulting in the coronavirus disease 2019 (COVID …

Predicting epitopes for vaccine development using bioinformatics tools

V Yurina, OR Adianingsih - Therapeutic advances in …, 2022 - journals.sagepub.com
Epitope-based DNA vaccine development is one application of bioinformatics or in silico
studies, that is, computational methods, including mathematical, chemical, and biological …

Ensemble machine learning model to predict SARS-CoV-2 T-cell epitopes as potential vaccine targets

SNH Bukhari, A Jain, E Haq, A Mehbodniya, J Webber - Diagnostics, 2021 - mdpi.com
An ongoing outbreak of coronavirus disease 2019 (COVID-19), caused by a single-stranded
RNA virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has …

COVID‐19: A systematic review and update on prevention, diagnosis, and treatment

H Aghamirza Moghim Aliabadi… - MedComm, 2022 - Wiley Online Library
Since the rapid onset of the COVID‐19 or SARS‐CoV‐2 pandemic in the world in 2019,
extensive studies have been conducted to unveil the behavior and emission pattern of the …

Current and prospective computational approaches and challenges for developing COVID-19 vaccines

W Hwang, W Lei, NM Katritsis, M MacMahon… - Advanced drug delivery …, 2021 - Elsevier
Abstract SARS-CoV-2, which causes COVID-19, was first identified in humans in late 2019
and is a coronavirus which is zoonotic in origin. As it spread around the world there has …

Nano-enabled COVID-19 vaccines: meeting the challenges of durable antibody plus cellular immunity and immune escape

AE Nel, JF Miller - ACS nano, 2021 - ACS Publications
At the time of preparing this Perspective, large-scale vaccination for COVID-19 is in
progress, aiming to bring the pandemic under control through vaccine-induced herd …

Designing multi-epitope-based vaccine targeting surface immunogenic protein of Streptococcus agalactiae using immunoinformatics to control mastitis in dairy cattle

RK Pathak, B Lim, DY Kim, JM Kim - BMC Veterinary Research, 2022 - Springer
Background Milk provides energy as well as the basic nutrients required by the body. In
particular, milk is beneficial for bone growth and development in children. Based on …

Vaccinomics: A future avenue for vaccine development against emerging pathogens

J de la Fuente, M Contreras - Expert Review of Vaccines, 2021 - Taylor & Francis
Introduction Vaccines are a major achievement in medical sciences, but the development of
more effective vaccines against infectious diseases is essential for prevention and control of …